全球學術和非營利組織的附屬條款和協議（2019-2024）

本報告提供了有關公司與學術和非營利組織合作的原因和條件的詳細資訊和分析。這些協議往往是多方面的，從聯合研發開始，一直到成果的商業化。

本報告詳細介紹了 2019 年以來生命科學領域宣布的 3,938 項學術和非營利協議。

該報告對學術和非營利性合約趨勢、領先公司、主要合約金額和合約財務進行了全面回顧，您可以了解哪些組織正在與哪些組織簽訂合作協議。

本報告從財務角度評估學術和非營利組織的交易條款和價值，包括交易總額、預付款、里程碑和特許權使用費率等信息，以幫助讀者了解交易的財務方面現在可以分析和比較的值。

本報告的中間部分考察了學術和非營利合作夥伴領域的領先交易撮合者。報告主要交易的交易價值以及學術和非營利組織中最活躍的交易撮合者，讓讀者了解哪些公司在這個充滿活力的交易市場中取得了成功。

學術和非營利組織的線上交易記錄包含在本報告末尾，採用以下目錄格式：

• 公司名稱（A-Z）
• 發展階段
• 交易類型
• 治療重點領域
• 技術類型
• 此外，我們也會記錄公司及其關聯公司向美國證券交易委員會提交的合約文件（如果有）。雖然許多公司想要詳細的付款條款，但在付款方式方面，細節才是王道，而合約文件可以提供新聞稿和資料庫所無法提供的洞察力。
• 本報告也包含一些圖表，顯示 2019 年以來學術和非營利合作與交易的趨勢和動態。
• 總而言之，本報告提供了未來交易撮合者需要了解的有關學術和非營利性研究、開發和商業化合作夥伴關係的所有資訊。

主要優點

該報告為讀者提供了以下主要好處：

• 有關學術和非營利組織合約趨勢的詳細資訊（2019 年及以後）
• 取得交易金額、預付款、里程碑和版稅率數據
• 學術和非營利組織與主要生物製藥公司簽署的實際協議：查看詳細信息
• 確定學術和非營利組織中最活躍的交易撮合者（2019 年及以後）
• 公司過去同意的主要合約條件的說明
• 進行盡職調查：評估向合作夥伴公司提出的合約條款的適當性

調查範圍

• 本報告旨在讓讀者深入了解和了解學術和非營利組織的趨勢和結構以及世界領先公司進行的交易。

學術和非營利組織合作條件和合約詳細資訊：

• 生物製藥產業的學術和非營利組織交易趨勢（2019 年及以後）
• 取得交易金額、預付款、里程碑和版稅率數據
• 取得主要製藥公司的合約文件
• 與主要學術和非營利組織的交易金額（2019 年起）
• 學術界和非營利組織最活躍的交易撮合者（2019 年起）

此報告列出了可用合約的以下資訊：

• 公司名稱（A-Z）
• 總交易金額
• 合約簽訂時的開發階段
• 合約組成部分的類型
• 具體治療標靶
• 技術類型
• 每筆交易的標題都透過網路連結連結到交易記錄的線上版本以及合約文件（如果有），從而可以輕鬆按需存取每份合約文件。

透過分析實際合同，可以評估：

• 授予或選擇的具體權利是什麼？
• 合約實際上賦予了合作夥伴公司什麼？
• 授予哪些類型的專有權？
• 合約的付款結構是怎樣的？
• 如何審核銷售和付款？
• 條款和條件是什麼？
• 合約的主要條款是如何定義的？
• 智慧財產權的處理和所有權如何？
• 誰負責商業化？
• 誰負責開發、供應和製造？
• 如何管理保密和發布？
• 如何解決爭議？
• 什麼情況下可以取消合約？
• 如果所有者發生變化會怎樣？
• 已就何種類型的分授權或分包條款達成協議？
• 公司主張哪些樣板條款？
• 根據合作夥伴關係或交易的類型，哪些樣板條款看起來有所不同？
• 公司對契約法主張哪一個管轄權？

目錄

摘要整理

第2章 學術及非營利團體的交易趨勢

• 簡介
• 學術及非營利團體的長期性的聯盟趨勢
• 在學術及非營利團體最活躍的交易商
• 學術及非營利團體的聯盟趨勢:各交易類型
• 學術及非營利團體的聯盟趨勢:各治療領域
• 學術及非營利團體的聯盟趨勢:各技術種類
• 學術及非營利團體的聯盟條件
  • 學術及非營利團體的聯盟的交易總額
  • 學術及非營利團體的交易的預付款金
  • 學術及非營利團體的交易的里程金
  • 學術及非營利團體的特許權率

第三章學術與非營利組織的重大交易

• 簡介
• 學術和非營利組織的主要交易：交易金額

第 4 章學術與非營利組織中最活躍的交易撮合者

• 簡介
• 學術和非營利組織中最活躍的交易撮合者
• 最活躍的學術和非營利合作夥伴：簡介

第五章學術與非營利組織的合約交易清單

• 簡介
• 學術和非營利組織合約交易列表

第 6 章學術與非營利組織交易趨勢：依技術類型劃分

附錄

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 report provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of 3,938 Academic and Non-Profit agreements announced in the life sciences since 2019.

The report takes the reader through a comprehensive review Academic and Non-Profit deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Academic and Non-Profit partnering deals.

The report presents financial deal term values for Academic and Non-Profit deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Academic and Non-Profit partnering field; both the leading deal values and most active Academic and Non-Profit dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

Online deal records of Academic and Non-Profit deals are included towards the end of the report in a directory format by:

• Company A-Z
• Stage of development
• Deal type
• Therapy focus
• Technology type
• In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.
• The initial chapters of this report provide an orientation of Academic and Non-Profit dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Academic and Non-Profit dealmaking since 2019, including details of headline, upfront, milestone and royalty terms.
• Chapter 3 provides a review of the leading Academic and Non-Profit deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
• Chapter 4 provides a comprehensive listing of the top 25 most active companies in Academic and Non-Profit dealmaking with a brief summary followed by a comprehensive listing of Academic and Non-Profit deals announded by that company, as well as contract documents, where available.
• Chapter 5 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2019, where a contract document is available in the public domain. Each deal title links via hyperlink to an online version of the deal record and contract document, providing easy access to each contract document on demand.
• Chapter 6 provides a comprehensive and detailed review of Academic and Non-Profit partnering deals signed and announced since Jan 2019. The chapter is organized by specific technology type. Each deal title links via hyperlink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.
• A comprehensive series of appendices is provided organized by Academic and Non-Profit partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via hyperlinkto an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.
• The report also includes numerous tables and figures that illustrate the trends and activities in Academic and Non-Profit partnering and dealmaking since 2019.
• In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Academic and Non-Profit technologies and products.

Key benefits

Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 provides the reader with the following key benefits:

• In-depth understanding of Academic and Non-Profit deal trends since 2019
• Access to headline, upfront, milestone and royalty data
• Detailed access to actual Academic and Non-Profit contracts entered into by leading biopharma companies
• Identify most active Academic and Non-Profit dealmakers since 2019
• Understand the key deal terms companies have agreed in previous deals
• Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

• Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024 is intended to provide the reader with an in-depth understanding and access to Academic and Non-Profit trends and structure of deals entered into by leading companies worldwide.

Academic and Non-Profit Partnering Terms and Agreements includes:

• Trends in Academic and Non-Profit dealmaking in the biopharma industry since 2019
• Access to headline, upfront, milestone and royalty data
• Access to Academic and Non-Profit contract documents
• Leading Academic and Non-Profit deals by value since 2019
• Most active Academic and Non-Profit dealmakers since 2019

In Global Academic and Non-Profit Partnering Terms and Agreements 2019-2024, the available deals are listed by:

• Company A-Z
• Headline value
• Stage of development at signing
• Deal component type
• Specific therapy target
• Technology type
• Each deal title links via hyperlink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Analyzing actual contract agreements allows assessment of the following:

• What are the precise rights granted or optioned?
• What is actually granted by the agreement to the partner company?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are IPRs handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes to be resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Academic and Non-Profit dealmaking

• 2.1. Introduction
• 2.2. Academic and Non-Profit partnering over the years
• 2.3. Most active Academic and Non-Profit dealmakers
• 2.4. Academic and Non-Profit partnering by deal type
• 2.5. Academic and Non-Profit partnering by therapy area
• 2.6. Academic and Non-Profit partnering by technology type
• 2.7. Deal terms for Academic and Non-Profit partnering
  • 2.7.1 Academic and Non-Profit partnering headline values
  • 2.7.2 Academic and Non-Profit deal upfront payments
  • 2.7.3 Academic and Non-Profit deal milestone payments
  • 2.7.4 Academic and Non-Profit royalty rates

Chapter 3 - Leading Academic and Non-Profit deals

• 3.1. Introduction
• 3.2. Top Academic and Non-Profit deals by value

Chapter 4 - Most active Academic and Non-Profit dealmakers

• 4.1. Introduction
• 4.2. Most active Academic and Non-Profit dealmakers
• 4.3. Most active Academic and Non-Profit partnering company profiles

Chapter 5 - Academic and Non-Profit contracts dealmaking directory

• 5.1. Introduction
• 5.2. Academic and Non-Profit contracts dealmaking directory

Chapter 6 - Academic and Non-Profit dealmaking by technology type

Appendices

• Appendix 1 - Academic and Non-Profit deals by company A-Z
• Appendix 2 - Academic and Non-Profit deals by stage of development
• Appendix 3 - Academic and Non-Profit deals by deal type
• Appendix 4 - Academic and Non-Profit deals by therapy area
• Appendix 5 - Deal type definitions
• Appendix 6 - Further reading
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

Table of figures

• Figure 1: Academic/Non-Profit partnering since 2019
• Figure 2: Active Academic/Non-Profit dealmaking activity 2019-2024
• Figure 3: Academic/Non-Profit partnering by deal type since 2019
• Figure 4: Academic/Non-Profit partnering by disease type since 2019
• Figure 5: Academic/Non-Profit partnering by technology type since 2019
• Figure 6: Academic/Non-Profit deals with a headline value
• Figure 7: Academic/Non-Profit deals with an upfront value
• Figure 8: Academic/Non-Profit deals with a milestone value
• Figure 9: Academic/Non-Profit deals with a royalty rate value
• Figure 10: Top Academic/Non-Profit deals by value since 2019
• Figure 11: Most active Academic/Non-Profit dealmakers 2019-2024